Postoperative adjuvant chemotherapy or BCG for colon cancer: Results from NSABP protocol C-01

Journal of the National Cancer Institute

Volumn 80, Issue 1, 1988, Pages 30-36

  Wolmark, Norman ^a   Fisher, Bernard ^a   Rockette, Howard ^a   Redmond, Carol ^a   Wickerham, D Lawrence ^a   Fisher, Edwin R ^a   Jones, Judith ^a   Glass, Andrew ^b   Lerner, Harvey ^b   Lawrence, Walter ^b   Prager, David ^b   Wexler, Marvin ^b   Evans, James ^b   Cruz, Anatolio ^b   Dimitrov, Nikolay ^b   Jochimsen, Peter ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; FLUOROURACIL; SEMUSTINE; VINCRISTINE;

ADJUVANT CHEMOTHERAPY; ADJUVANT IMMUNOTHERAPY; BONE MARROW TOXICITY; COLON CANCER; CONTROLLED STUDY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; SKIN ULCER;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BCG VACCINE; CLINICAL TRIALS; COLONIC NEOPLASMS; FEMALE; FLUOROURACIL; HUMAN; MALE; MIDDLE AGE; POSTOPERATIVE PERIOD; PROGNOSIS; RANDOM ALLOCATION; SEMUSTINE; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; VINCRISTINE;

EID: 0023855192     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/80.1.30     Document Type: Article

References (29)

1. Higgins GA, Amadeo JH, McElhinney J, et al. Efficacy of prolonged intermittent therapy with combined 5-fluorouracil and methyl- CCNU following resection for carcinoma of the large bowel. Cancer 1984;53:1-8.
2. Gastrointestinal Tumor Study Group. Adjuvant therapy of colon cancer. Results of a prospectively randomized trial. N Engl J Med 1984;310:737-743.
3. Mrazek R, Economou S, McDonald G, et al. Prophylactic and adjuvant use of nitrogen mustard in the surgical treatment of cancer. Ann Surg 1959; 150:745.
4. Holden WD, Dixon WJ, Kuzma JW. The use of triethylenethiophos- phamide as an adjuvant to the surgical treatment of colorectal carcinoma. Ann Surg 1967; 165:481.
5. Rousselot LM, Cole DR, Slattery J, et al. Intraluminal chemotherapy adjuvant to operation for cancer of the colon and rectum. Follow up report of 83 cases. Ann Surg 1965;162:407.
6. Higgins GA, Dwight RW, Smith JV, et al. Fluorouracil as an adjuvant to surgery in carcinoma of the colon. Arch Surg 1971;102:339-343.
7. Higgins GA, Humphrey E, Juler G, et al. Adjuvant chemotherapy in the surgical treatment of large bowel cancer. Cancer 1976;38:1461-1467.
8. Higgins GA, Lyndon LE, Dwight RW, et al. The case for adjuvant 5-fluorouracil in colorectal cancer. Cancer Clin Trials 1978;1:35-41.
9. Higgins GA, Donaldson RC, Humphrey EW, et al. Adjuvant therapy for large bowel cancer update of Veterans Administration Surgical Oncology Group Trials. Surg Clin North Am 1981;61:1311-1320.
10. Grage TB, Hill GJ, Cornell GN, et al. Adjuvant chemotherapy in large bowel cancer. (Update analysis of single agent chemotherapy.) In: Jones SE, Salmons SE, eds. Adjuvant therapy of cancer II. New York: Grune and Stratton, 1979:587-594.
11. Grage TB, Moss SE. Adjuvant chemotherapy in cancer of the colon and rectum: demonstration of effectiveness of prolonged 5-FU chemotherapy in a prospectively controlled, randomized trial. Surg Clin North Am 1981;61:1321-1329.
12. Moertel CG, Shutt AJ, Hahn RG, et al. Therapy of advanced colorectal cancer with a combination of 5-fluorouracil, methyl-1, 3-cis(2-chloroethyl)-l-nitrosourea and vincristine. J Natl Cancer Inst 1975;54:69-71.
13. Baker LH, Talley RW, Matter R. Phase III comparison of the treatment of advanced gastrointestinal cancer with bolus weekly 5-FU vs methyl-CCNU plus bolus weekly 5-FU. Cancer 1976;38:1-7.
14. Falkson G, Falkson HC. Fluorouracil, methyl CCNU, and vincristine in cancer of the colon. Cancer 1976;38:1468-1470.
15. Corbett TH, Griswold DP Jr, Roberts BJ, et al. A mouse colon- tumor model for experimental therapy. Cancer Chemother Rep (Part 2) 1975;5:169-186.
16. Corbett TH, Griswold DP Jr, Roberts BJ, et al. Evaluation of single agents and combinations of chemotherapeutic agents in mouse colon carcinomas. Cancer 1977;40:2660-2680.
17. Zbar B, Bernstein I, Tanaka T, et al. Tumor immunity produced by the intradermal inoculation of living tumor cells and living Mycobacterium bov'ts (strain BCG). Science 1970;170:1217.
18. Mavligit GM, et al. Clinical immunotherapy as adjuvant therapy for colon and rectal cancer. In: Enker WE, ed. Carcinoma of the colon and rectum. Chicago: Year Book Medical Publishers Inc., 1978:133-171.
19. Mavligit GM, Gutterman JU, Malahy MA, et al. Adjuvant immunotherapy and chemoimmunotherapy in colorectal cancer. (Dukes’ Class C): prolongation of disease-free interval and survival. Cancer 1977;40:2726-2730.
20. Fisher B, Wolmark N, Rockette C, et al. Postoperative adjuvant chemotherapy or radiation therapy for rectal cancer: results from NSABP protocol R-01. J Natl Cancer Inst 1988;80:21-29.
21. Dukes CE. The classification of cancer of the rectum. J Pathol Bacteriol 1932;35:332-339.
22. Fisher B, Bauer M, Margolese R, et al. Five year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med 1985;312:665-673.
23. Cutler SJ, Ederer F. Maximum utilization of the life table method in analyzing survival. J Chronic Dis 1958;8:699-712.
24. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-170.
25. Peto R, Peto J. Asymptotically efficient rank invariant test procedures. J R Stat Soc [A] 1972;135:185-206.
26. Hankey BF, Myers MH. Evaluating differences in survival between two groups of patients. J Chronic Dis 1971;24:523-531.
27. Robins J, Breslow N, Greenland S. Estimators of Mantel-Haenszel variance consistent in both sparse data and large-strata limiting models. Biometrics 1986;42:311-323.
28. Cox DR. Regression models and life tables. J R Stat Soc 1972;34:187-220.
29. Boice JD Jr, Greene MH, Killen JY Jr, et al. Leukemia and preleukemia after adjuvant treatment of gastrointestinal cancer with semustine (methyl-CCNU). N Engl J Med 1983;309:1079-1084.